Schrole (ASX:SCL) has raised capital
Schrole has raised US$1.5 million via a private placement to aid strategy acceleration and expansion.
Schrole is an Australian company that delivers innovative software and training service solutions within the education sector. Schrole combines modernism and passion across four divisions: ISS Schrole Advantage, an integrated vacancy management system enabling schools to streamline teacher recruitment and candidate management activities; Schrole Cover, an application that helps to fill vacancies for schools, hospitality and hospitals; Schrole Verify, a simplified and customized background screening solution; and Schrole ETAS provides customized training solutions to the education and resources industries.
Oaklins’ team in Australia acted as lead manager in this transaction.
![](/api/deal-hero-image/106656/deal-hero-image.jpg)
![](/api/deal-party-images/106656/deal-parties.png)
Talk to the deal team
Related deals
Amcomri Group has completed an initial public offering
Amcomri Group plc has successfully completed an initial public offering (IPO) on the AIM Market of the London Stock Exchange, successfully raising US$15 million (£12 million) through a placing. The IPO will enable Amcomri to further its ‘Buy-Improve-Build’ strategy in the UK engineering sector.
Learn moreTekova Oyj has completed a technical listing on the Nasdaq First North Growth Market Finland
Tekova Oyj has successfully completed a technical listing (IPO) on the Nasdaq First North Growth Market Finland. This transaction marks a significant milestone in the company’s growth strategy, enhancing its visibility and access to capital markets.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn more